Tirzepatide, sold under the brand name Mounjaro, is a dual-action medication that targets both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors
Psychoneuroendocrinology, 34(6), 917-923
Note this is not a "skinny jab" - 15% takes you from 20 stone down to 17
Call your healthcare provider if you have symptoms, such as pain in your upper stomach (abdomen), fever, yellowing of the skin or eyes (jaundice), or clay-colored stools Increased risk of low blood sugar (hypoglycemia), especially those who also take medicines for diabetes such as insulin or sulfonylureas
Before beginning any treatment, it's essential to consult with a licensed healthcare provider to ensure the best approach for your individual health needs.